Abstract
The paper by Zahid Rasul Niazi, Naqab Khan, Samiullah Khan, Mehboob Alam, Mohammad Amjad Kamal entitled “Potential Application of Venom Proteins in Designing of Medicines for Treating Human Neurodegenerative Disorders” is being retracted from the Protein & Peptide Letters, Volume 25, Issue 7, due to the use of Figure from an earlier publication without permission or attribution. In addition, some text was copied and used in the paper without quotation marks or proper citation.
Protein & Peptide Letters
Title:Retraction Notice: Potential Application of Venom Proteins in Designing of Medicines for Treating Human Neurodegenerative Disorders
Volume: 25 Issue: 7
Author(s): Zahid Rasul Niazi, Naqab Khan, Samiullah Khan, Mehboob Alam and Mohammad Amjad Kamal*
Affiliation:
- Novel Global Community Educational Foundation, Sydney,Australia
Abstract: The paper by Zahid Rasul Niazi, Naqab Khan, Samiullah Khan, Mehboob Alam, Mohammad Amjad Kamal entitled “Potential Application of Venom Proteins in Designing of Medicines for Treating Human Neurodegenerative Disorders” is being retracted from the Protein & Peptide Letters, Volume 25, Issue 7, due to the use of Figure from an earlier publication without permission or attribution. In addition, some text was copied and used in the paper without quotation marks or proper citation.
Export Options
About this article
Cite this article as:
Niazi Rasul Zahid , Khan Naqab , Khan Samiullah , Alam Mehboob and Kamal Amjad Mohammad *, Retraction Notice: Potential Application of Venom Proteins in Designing of Medicines for Treating Human Neurodegenerative Disorders, Protein & Peptide Letters 2018; 25 (7) . https://dx.doi.org/10.2174/0929866525666180614120407
DOI https://dx.doi.org/10.2174/0929866525666180614120407 |
Print ISSN 0929-8665 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5305 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Huntingtons Disease: New Frontiers for Molecular and Cell Therapy
Current Drug Targets The Management and Alternative Therapies for Comorbid Sleep Disorders in Epilepsy
Current Neuropharmacology EPO and EPO-Receptor System as Potential Actionable Mechanism for the Protection of Brain and Heart in Refractory Epilepsy and SUDEP
Current Pharmaceutical Design Navigating the Sea Changes in Patent Law to Successfully Build Value
Technology Transfer and Entrepreneurship (Discontinued) Synthesis and Evaluation of Anticonvulsant Activities of 4-Phenylpiperidin- 2-one Derivatives
Letters in Drug Design & Discovery Safety Profile of the Newest Antiepileptic Drugs: A Curated Literature Review
Current Pharmaceutical Design Current Trends in the Application of Nanoparticles in Drug Delivery
Current Medicinal Chemistry New Glycoside Esters from the Aerial Parts of Artemisia absinthium Linn.
The Natural Products Journal Phosphodiesterase 5 Inhibitors in the Treatment of Erectile Dysfunction
Current Pharmaceutical Design Neuropharmacological Profile of Gamma-Decanolactone on Chemically-induced Seizure in Mice
Central Nervous System Agents in Medicinal Chemistry Brain Adaptation to Stressful Stimuli: A New Perspective on Potential Therapeutic Approaches Based on BDNF and NMDA Receptors
CNS & Neurological Disorders - Drug Targets A Review of Recent Patents on the ASICs as a Key Drug Target
Recent Patents on Biotechnology Expressed Emotion and Eating Disorders: An Updated Review
Current Psychiatry Reviews Biochemical, Molecular and Epigenetic Mechanisms of Valproic Acid Neuroprotection
Current Molecular Pharmacology Diagnostic Approach to Mitochondrial Disorders: the Need for a Reliable Biomarker
Current Molecular Medicine A Retrospective, Multi-Center Cohort Study Evaluating the Severity- Related Effects of Cerebrolysin Treatment on Clinical Outcomes in Traumatic Brain Injury
CNS & Neurological Disorders - Drug Targets Allosteric Modulators of GABAB Receptors: Mechanism of Action and Therapeutic Perspective
Current Neuropharmacology Group I Metabotropic Receptor Neuroprotection Requires Akt and Its Substrates that Govern FOXO3a, Bim, and β-Catenin During Oxidative Stress
Current Neurovascular Research Reactive Astrocytes as Potential Manipulation Targets in Novel Cell Replacement Therapy of Parkinsons Disease
Current Drug Targets An Update on GABAρ Receptors
Current Neuropharmacology